Public Employees Retirement System of Ohio bought a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 62,394 shares of the insurance provider’s stock, valued at approximately $24,784,000. Public Employees Retirement System of Ohio owned about 0.05% of Humana at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in Humana during the second quarter valued at $4,138,160,000. Capital International Investors increased its position in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after buying an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC increased its position in Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after buying an additional 1,398,774 shares in the last quarter. State Street Corp raised its stake in shares of Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after buying an additional 97,211 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Humana by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider’s stock valued at $812,540,000 after buying an additional 23,732 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.
Humana Stock Down 1.5%
Shares of HUM opened at $386.92 on Friday. The business’s 50 day moving average is $385.60 and its 200 day moving average is $288.47. The company has a market capitalization of $46.46 billion, a PE ratio of 36.61, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.
Wall Street Analyst Weigh In
HUM has been the subject of a number of recent research reports. Oppenheimer reiterated an “outperform” rating and set a $405.00 price objective on shares of Humana in a research note on Thursday, July 30th. Weiss Ratings raised shares of Humana from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 14th. Seaport Research Partners lowered shares of Humana to a “neutral” rating in a research report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Humana in a research report on Thursday, July 30th. They issued a “hold” rating for the company. Finally, TD Cowen raised their price objective on shares of Humana from $350.00 to $370.00 and gave the company a “hold” rating in a research report on Friday, July 31st. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $403.91.
Read Our Latest Report on Humana
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
